AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
An integrated virtual screening strategy based on molecular fingerprint similarity, pharmacophore models, molecular docking, and molecular dynamics simulation is proposed and three promising lead compounds targeting RIPK3 for AD treatment are offered.
Findings highlight Withaferin A as a promising natural inhibitor of UBE2J1 and provide a foundation for future experimental validation aimed at developing targeted therapies against ovarian cancer.
The comprehensive in silico methodology in this work illuminated the inhibitory mechanism of LY3202626 and top hit compounds against BACE1 activity for the first time, which will be highly valuable in further optimization and structural refinement using various functional group modifications to yield more potent next-g...
A transferable pipeline for the in silico design of SMIs is established and several top candidates with strong potential for subsequent in vitro validation for the treatment of Nck1-related immune system diseases are identified.
By repurposing Flavoxate, this work proposes a clinically translatable strategy to mitigate NLRP3-mediated neuroinflammation in AD, offering a potential disease modifying therapy with an established safety profile and underscores the significance of computational approaches in bridging the gap between preclinical disco...
This integrated virtual screening and experimental validation approach enabled the identification of candidate USP7-inhibitory scaffolds with preliminary antiproliferative activity that warrant further medicinal chemistry optimization, orthogonal validation, and mechanistic characterization to establish their potential...
The findings from molecular docking, 500-ns molecular dynamics simulations, MM-GBSA calculations, and alanine scanning analyses collectively corroborate a stable binding mode of BTB11556 within the MPO active site, support further investigation of BTB11556 as a candidate compound associated with MPO-targeted therapeuti...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.